Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response

Figure 2

A. Intradermal application on the abdominal wall; B. Continuous infusion of GM-CSF at the vaccine site using a minipump. Vaccines are administered intradermally on alternating sides of the abdominal wall (A). Before clinical administration, the irradiated autologous tumor cells are thawed, washed extensively, and resuspended in 1 mL of sterile saline. Immediately following the vaccine application a catheter is placed at the vaccine site and GM-CSF is infused continuously at a rate of 50 μg/24 h for a total of 6 days using an osmotic minipump (Smiths Medical, Kirchseeon, Germany) (B).

Back to article page